Nomogram Predicting Overall Survival in Patients With Locally Advanced Cervical Cancer Treated With Radiochemotherapy Including Image-Guided Brachytherapy: A Retro-EMBRACE Study.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 09 2021
Historique:
received: 21 10 2020
revised: 16 04 2021
accepted: 20 04 2021
pubmed: 2 5 2021
medline: 5 10 2021
entrez: 1 5 2021
Statut: ppublish

Résumé

To present a nomogram for prediction of overall survival (OS) in patients with locally advanced cervical cancer (LACC) undergoing definitive radiochemotherapy including image-guided adaptive brachytherapy (IGABT). Seven hundred twenty patients with LACC treated with radiochemotherapy including IGABT in 12 institutions (median follow-up 56 months) were analyzed; 248 deaths occurred. Thirteen candidate predictors for OS were a priori chosen on the basis of the literature and expert knowledge. Missing data (7.2%) were imputed using multiple imputation and predictive mean matching. Univariate analysis with a multivariable Cox regression model for OS stratified by center was performed. Stepwise selection of predictive factors with the Akaike Information Criterion was used to obtain a predictive model and construct a nomogram for OS predictions 60 months from diagnosis; this was internally validated by concordance probability as a measure of discrimination and a calibration plot. Thirteen potential predictive factors were evaluated; 10 factors reached statistical significance in univariate analysis (age, Hemoglobin, FIGO Stage This is the first nomogram to predict OS in patients with LACC treated with IGABT. In addition to previously reported factors (age, FIGO

Identifiants

pubmed: 33932530
pii: S0360-3016(21)00404-1
doi: 10.1016/j.ijrobp.2021.04.022
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-177

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Alina Emiliana Sturdza (AE)

Department of Radiation Oncology, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria. Electronic address: alina.sturdza@meduniwien.ac.at.

Richard Pötter (R)

Department of Radiation Oncology, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.

Michael Kossmeier (M)

Department of Statistics, Medical University of Vienna, Vienna, Austria.

Kathrin Kirchheiner (K)

Department of Radiation Oncology, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.

Umesh Mahantshetty (U)

Department of Radiation Oncology, Tata Memorial Hospital, Dr. Mahantshetty Homi Bhabha National Institute, Mumbai, India.

Christine Haie-Meder (C)

Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.

Jacob Christian Lindegaard (JC)

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

Ina Jurgenliemk-Schulz (I)

Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.

Li Tee Tan (LT)

Department of Clinical Oncology, Cambridge University Addenbrooke's Hospital, Cambridge, United Kingdom.

Peter Hoskin (P)

Mount Vernon Cancer Centre, London, United Kingdom.

Erik van Limbergen (E)

Department of Oncology, KU Leuven-University of Leuven, Experimental Radiation Oncology, Leuven, Belgium.

Charles Gillham (C)

St Lukes Radiation Oncology Network, Rathgar, Dublin, Ireland.

Barbara Segedin (B)

Institute of Oncology, Ljubljana, Slovenia.

Ekkasit Tharavichitkul (E)

The Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Elena Villafranca Iturre (EV)

Department of Oncology, University of Navarra, Pamplona, Spain.

Lars Ulrik Fokdal (LU)

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

Stephan Polterauer (S)

Department of Obstetrics and Gynecology, Gynecologic Oncology Group Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Christian Kirisits (C)

Department of Radiation Oncology, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.

Kari Tanderup (K)

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH